| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
CLINICAL SCIENCE |


,

Departments of *Clinical Epidemiology and Biostatistics and
Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; and
Dianet Dialysis Centers, Amsterdam and Utrecht, The Netherlands.
Correspondence to Dr. Fabian Termorshuizen, Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Phone: +31-20-5663607; Fax: +31-20-6912683;
ABSTRACT. Various studies indicate that fair comparisons of mortality rates between hemodialysis (HD) patients and peritoneal dialysis (PD) patients are difficult because of differences in patient characteristics, because of nonconstant relative risks of death (RR), and because the survival times of patients who switch treatment modalities can be censored in different ways. The differences in mortality rates between HD and PD patients were investigated in an analysis in which these potential sources of bias were taken into account. The Netherlands Cooperative Study on the Adequacy of Dialysis is a multicenter, prospective, observational, cohort study in which new patients with ESRD are monitored until transplantation or death. A multivariate Cox regression analysis was used to analyze the mortality data according to treatment modality (HD, n = 742; PD, n = 480). No statistically significant differences in adjusted mortality rates between HD and PD patients were observed during the first 2 yr of dialysis. In the years thereafter, increases in mortality rates for PD patients and resulting decreases in RR in favor of HD were observed (e.g., months 24 to 36, adjusted RR, 0.53; 95% confidence interval, 0.31 to 0.91). This tendency was observed especially among patients
60 yr of age and was not influenced by the censoring strategy. These results suggest that long-term use of PD, especially among elderly patients, is associated with increases in mortality rates. Further analyses are required to determine the potential role of dialysis adequacy in the observed long-term differences in mortality rates between HD and PD patients and to establish the possible survival benefits for PD patients who switch to HD in time. E-mail: FTermorshuizen@cs.com
This article has been cited by other articles:
![]() |
R. van den Berg, T. T. Cnossen, C. J. A. M. Konings, J. P. Kooman, F. M. van der Sande, and K. M. L. Leunissen Different treatment options in peritoneal dialysis NDT Plus, October 1, 2008; 1(suppl_4): iv14 - iv17. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parikova, W. Smit, M. M. Zweers, D. G. Struijk, and R. T. Krediet Free water transport, small pore transport and the osmotic pressure gradient Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2350 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella Reimbursement and economic factors influencing dialysis modality choice around the world Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Viglino, L. Neri, S. Alloatti, G. Cabiddu, R. Cocchi, A. Limido, G. Marinangeli, R. Russo, U. Teatini, and F. P. Schena Analysis of the factors conditioning the diffusion of peritoneal dialysis in Italy Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3601 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Couchoud, O. Moranne, L. Frimat, M. Labeeuw, V. Allot, and B. Stengel Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3246 - 3254. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data? Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Wiggins, S. P. McDonald, F. G. Brown, J. B. Rosman, and D. W. Johnson High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3005 - 3012. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Van Biesen, F. Verbeke, and R. Vanholder Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis Nephrol. Dial. Transplant., January 1, 2007; 22(1): 53 - 58. [Full Text] [PDF] |
||||
![]() |
R. Saxena and C. West Peritoneal dialysis: a primary care perspective. J Am Board Fam Med, July 1, 2006; 19(4): 380 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Inrig, J. L. Sun, Q. Yang, L. P. Briley, and L. A. Szczech Mortality by Dialysis Modality among Patients Who Have End-Stage Renal Disease and Are Awaiting Renal Transplantation Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 774 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Jaar, J. Coresh, L. C. Plantinga, N. E. Fink, M. J. Klag, A. S. Levey, N. W. Levin, J. H. Sadler, A. Kliger, and N. R. Powe Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease Ann Intern Med, August 2, 2005; 143(3): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonelli, B. Hemmelgarn, B. Manns, S. Davison, C. Bohm, S. Gourishankar, G. Pylypchuk, K. Yeates, and J. S. Gill Use and Outcomes of Peritoneal Dialysis among Aboriginal People in Canada J. Am. Soc. Nephrol., February 1, 2005; 16(2): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673